PARAMETRIC PORTFOLIO ASSOCIATES LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 91 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,233,000
+81.4%
198,832
+54.6%
0.00%
+100.0%
Q4 2021$1,782,000
-45.9%
128,643
-43.8%
0.00%
-50.0%
Q3 2021$3,292,000
-5.3%
229,056
+4.1%
0.00%0.0%
Q2 2021$3,478,000
+238.0%
220,014
+117.4%
0.00%
+100.0%
Q1 2021$1,029,000
+63.3%
101,189
+19.7%
0.00%
Q4 2020$630,000
+117.2%
84,534
+0.2%
0.00%
Q3 2020$290,000
-88.8%
84,345
-84.4%
0.00%
-100.0%
Q2 2020$2,583,000
+2509.1%
542,129
+998.1%
0.00%
Q1 2020$99,000
-9.2%
49,368
+56.6%
0.00%
Q4 2019$109,000
-32.7%
31,519
-44.3%
0.00%
Q3 2019$162,000
+157.1%
56,618
+239.9%
0.00%
Q2 2019$63,000
-94.0%
16,655
-87.1%
0.00%
-100.0%
Q1 2019$1,053,000
+12.4%
129,306
+11.4%
0.00%0.0%
Q4 2018$937,000
+1042.7%
116,110
+712.9%
0.00%
Q2 2018$82,000
+34.4%
14,284
+10.9%
0.00%
Q1 2018$61,000
+5.2%
12,877
+9.9%
0.00%
Q4 2017$58,0000.0%11,720
+5.9%
0.00%
Q3 2017$58,000
-60.3%
11,072
-26.0%
0.00%
Q3 2014$146,00014,9600.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders